Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Amoxicillin and Clavulanate Potassium for Oral Suspension Drops
Medication labelWhy this: Advisory · dailymed-animal
Amoxicillin and Clavulanate Potassium for Oral Suspension drops are indicated in the treatment of: Dogs: Skin and soft tissue infections such as wounds, abscesses, cellulitis, superficial/juvenile and deep pyoderma due to susceptible strains of the following organisms: β-lactamase-producing Staphylococcus aureus, non-β-lactamase-producing Staphylococcus aureus, Staphylococcus spp., Streptococcus spp., and E. coli. Periodontal infections due to susceptible strains of both aerobic and anaerobic bacteria. Amoxicillin and clavulanate potassium for oral suspension has been shown to be clinically effective for treating cases of canine periodontal disease. Cats: Skin and soft tissue infections such as wounds, abscesses, and cellulitis/dermatitis due to susceptible strains of the following organisms: β-lactamase-producing Staphylococcus aureus, non-β-lactamase-producing Staphylococcus aureus, Staphylococcus spp., Streptococcus spp., E. coli, Pasteurella multocida, and Pasteurella spp. Urinary tract infections (cystitis) due to susceptible strains of E. coli. Therapy may be initiated with Amoxicillin and Clavulanate Potassium for Oral Suspension prior to obtaining results from bacteriological and susceptibility studies. A culture should be obtained prior to treatment to determine susceptibility of the organisms to Amoxicillin and Clavulanate Potassium for Oral Suspension. Following determination of susceptibility results and clinical response to medication, therapy may be reevaluated.
- generic_name
- amoxicillin and clavulanate potassium
- product_names
- Amoxicillin and Clavulanate Potassium
- ndc
- 11695-7007, 11695-7007-1
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en